Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we
Repligen to Report Second Quarter 2024 Financial Results
Webcast and Conference Call to Be Held Tuesday, July 30, 2024, at 8:30 a.m. ETWALTHAM, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that
Repligen Reports Attempted Cybersecurity Incident
Repligen (RGEN) said Monday that certain files on its information systems had been illegally accessed by an unauthorized party, and it is currently investigating the cybersecurity incident.Repligen
Express News | Repligen Corp: Continues to Investigate the Matter to Determine Full Extent of Impact on Company
Express News | Repligen Corp: Does Not Anticipate That Incident Will Have Material Impact on Financial Condition or Results of Operations
Express News | Repligen Corp: Co's Ability to Serve Customers Has Also Not Been Impacted, and Its Information Systems Remain Operational and Undisrupted
Express News | Repligen Corp: As of Date of Report, Incident Has Not Had an Impact on Company's Business or Operations
Express News | Repligen Corp: On July 9, Discovered an Unauthorized Third Party Had Accessed Certain Files on Company's Information Systems
Deutsche Bank's Fresh Money List for 3Q
Should You Investigate Repligen Corporation (NASDAQ:RGEN) At US$126?
Repligen Corporation (NASDAQ:RGEN), might not be a large cap stock, but it received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US
Top Gap Ups and Downs on Wednesday: SAP, RACE, FDX and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
This Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Citigroup r
Express News | Repligen Corp : Deutsche Bank Raises to Buy From Hold; Cuts Target Price to $155 From $180
Repligen Raised to Buy From Hold by Deutsche Bank
Repligen Raised to Buy From Hold by Deutsche Bank
Deutsche Numis Upgrades Repligen(RGEN.US) to Buy Rating, Cuts Target Price to $155
Deutsche Numis analyst Justin Bowers upgrades $Repligen(RGEN.US)$ to a buy rating, and adjusts the target price from $180 to $155.According to TipRanks data, the analyst has a success rate of 49.5% an
Express News | Deutsche Bank Upgrades Repligen to Buy, Lowers Price Target to $155
RBC Cuts Price Target on Repligen to $190 From $221, Maintains Outperform Rating
Repligen (RGEN) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $165 to $225.
Express News | Repligen Corp : RBC Cuts Target Price to $190 From $221
Top 3 Health Care Stocks That Could Blast Off In June
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock's strength on days when prices go u